位置:首页 > 蛋白库 > O1509_MOUSE
O1509_MOUSE
ID   O1509_MOUSE             Reviewed;         308 AA.
AC   Q7TQQ0; A0A0U1RP41; Q9R0K3;
DT   18-JUL-2018, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   03-AUG-2022, entry version 148.
DE   RecName: Full=Olfactory receptor 1509 {ECO:0000305};
DE   AltName: Full=Odorant receptor 244-3 {ECO:0000303|PubMed:18214836, ECO:0000303|PubMed:22328155, ECO:0000303|PubMed:25185561, ECO:0000303|PubMed:25901328, ECO:0000303|PubMed:27019154};
DE   AltName: Full=Odorant receptor 83 {ECO:0000303|PubMed:10493742};
GN   Name=Olfr1509 {ECO:0000312|MGI:MGI:3031343};
GN   Synonyms=MOR244-3 {ECO:0000303|PubMed:18214836,
GN   ECO:0000303|PubMed:22328155, ECO:0000303|PubMed:25185561,
GN   ECO:0000312|MGI:MGI:3031343}, MOR83 {ECO:0000303|PubMed:10493742,
GN   ECO:0000312|MGI:MGI:3031343};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090 {ECO:0000312|EMBL:AAP71857.1};
RN   [1] {ECO:0000312|EMBL:BAA86125.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND TISSUE SPECIFICITY.
RC   STRAIN=129/SvJ {ECO:0000312|EMBL:BAA86125.1};
RX   PubMed=10493742; DOI=10.1523/jneurosci.19-19-08409.1999;
RA   Tsuboi A., Yoshihara S., Yamazaki N., Kasai H., Asai-Tsuboi H., Komatsu M.,
RA   Serizawa S., Ishii T., Matsuda Y., Nagawa F., Sakano H.;
RT   "Olfactory neurons expressing closely linked and homologous odorant
RT   receptor genes tend to project their axons to neighboring glomeruli on the
RT   olfactory bulb.";
RL   J. Neurosci. 19:8409-8418(1999).
RN   [2] {ECO:0000312|EMBL:AAL60958.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=11875048; DOI=10.1093/hmg/11.5.535;
RA   Young J.M., Friedman C., Williams E.M., Ross J.A., Tonnes-Priddy L.,
RA   Trask B.J.;
RT   "Different evolutionary processes shaped the mouse and human olfactory
RT   receptor gene families.";
RL   Hum. Mol. Genet. 11:535-546(2002).
RN   [3]
RP   ERRATUM OF PUBMED:11875048.
RA   Young J.M., Friedman C., Williams E.M., Ross J.A., Tonnes-Priddy L.,
RA   Trask B.J.;
RL   Hum. Mol. Genet. 11:1683-1683(2002).
RN   [4] {ECO:0000312|EMBL:AAP71857.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=14611657; DOI=10.1186/gb-2003-4-11-r71;
RA   Young J.M., Shykind B.M., Lane R.P., Tonnes-Priddy L., Ross J.A.,
RA   Walker M., Williams E.M., Trask B.J.;
RT   "Odorant receptor expressed sequence tags demonstrate olfactory expression
RT   of over 400 genes, extensive alternate splicing and unequal expression
RT   levels.";
RL   Genome Biol. 4:R71.1-R71.13(2003).
RN   [5] {ECO:0000312|Proteomes:UP000000589}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J {ECO:0000312|Proteomes:UP000000589};
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [6] {ECO:0000312|EMBL:EDL42235.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000312|EMBL:AAI19196.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8] {ECO:0000305}
RP   FUNCTION, ACTIVITY REGULATION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY,
RP   AND MUTAGENESIS OF HIS-56; MET-59; HIS-73; CYS-97; HIS-105; CYS-109;
RP   MET-118; CYS-127; MET-136; CYS-141; HIS-155; CYS-169; CYS-179; CYS-189;
RP   CYS-210; HIS-243; CYS-254; MET-298; HIS-300 AND CYS-307.
RX   PubMed=22328155; DOI=10.1073/pnas.1111297109;
RA   Duan X., Block E., Li Z., Connelly T., Zhang J., Huang Z., Su X., Pan Y.,
RA   Wu L., Chi Q., Thomas S., Zhang S., Ma M., Matsunami H., Chen G.Q.,
RA   Zhuang H.;
RT   "Crucial role of copper in detection of metal-coordinating odorants.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:3492-3497(2012).
RN   [9] {ECO:0000305}
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=18214836; DOI=10.1002/dneu.20612;
RA   Tian H., Ma M.;
RT   "Differential development of odorant receptor expression patterns in the
RT   olfactory epithelium: a quantitative analysis in the mouse septal organ.";
RL   Dev. Neurobiol. 68:476-486(2008).
RN   [10] {ECO:0000305}
RP   FUNCTION, ACTIVITY REGULATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   CYS-109.
RX   PubMed=25185561; DOI=10.1016/j.bpj.2014.07.031;
RA   Sekharan S., Ertem M.Z., Zhuang H., Block E., Matsunami H., Zhang R.,
RA   Wei J.N., Pan Y., Batista V.S.;
RT   "QM/MM model of the mouse olfactory receptor MOR244-3 validated by site-
RT   directed mutagenesis experiments.";
RL   Biophys. J. 107:L5-L8(2014).
RN   [11] {ECO:0000305}
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25901328; DOI=10.1073/pnas.1503054112;
RA   Block E., Jang S., Matsunami H., Sekharan S., Dethier B., Ertem M.Z.,
RA   Gundala S., Pan Y., Li S., Li Z., Lodge S.N., Ozbil M., Jiang H.,
RA   Penalba S.F., Batista V.S., Zhuang H.;
RT   "Implausibility of the vibrational theory of olfaction.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:E2766-E2774(2015).
RN   [12] {ECO:0000305}
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=27019154; DOI=10.1016/j.ab.2016.03.006;
RA   Burger J.L., Jeerage K.M., Bruno T.J.;
RT   "Direct nuclear magnetic resonance observation of odorant binding to mouse
RT   odorant receptor MOR244-3.";
RL   Anal. Biochem. 502:64-72(2016).
RN   [13] {ECO:0000305}
RP   FUNCTION, ACTIVITY REGULATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   CYS-254; ARG-260 AND LYS-269.
RX   PubMed=29659735; DOI=10.1093/chemse/bjy022;
RA   Zhang R., Pan Y., Ahmed L., Block E., Zhang Y., Batista V.S., Zhuang H.;
RT   "A Multispecific Investigation of the Metal Effect in Mammalian Odorant
RT   Receptors for Sulfur-containing Compounds.";
RL   Chem. Senses 43:357-366(2018).
CC   -!- FUNCTION: Olfactory receptor that is activated by the binding of
CC       organosulfur odorants with thioether groups such as
CC       (methylthio)methanethiol (MTMT) and bis(methylthiomethyl) disulfide
CC       (PubMed:22328155, PubMed:25185561, PubMed:25901328, PubMed:29659735).
CC       Also binds odorants cis-cyclooctene and tert-butyl mercaptan
CC       (PubMed:27019154). The activity of this receptor is mediated by G
CC       proteins which activate adenylyl cyclase (Potential).
CC       {ECO:0000269|PubMed:22328155, ECO:0000269|PubMed:25185561,
CC       ECO:0000269|PubMed:25901328, ECO:0000269|PubMed:27019154,
CC       ECO:0000269|PubMed:29659735, ECO:0000305}.
CC   -!- ACTIVITY REGULATION: Copper binding enhances receptor activity in
CC       response to odorant binding. {ECO:0000269|PubMed:22328155,
CC       ECO:0000269|PubMed:25185561, ECO:0000269|PubMed:29659735}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000255,
CC       ECO:0000255|RuleBase:RU363047, ECO:0000269|PubMed:22328155,
CC       ECO:0000269|PubMed:27019154, ECO:0000269|PubMed:29659735,
CC       ECO:0000305|PubMed:25185561, ECO:0000305|PubMed:25901328}; Multi-pass
CC       membrane protein {ECO:0000255, ECO:0000255|RuleBase:RU363047,
CC       ECO:0000269|PubMed:27019154}.
CC   -!- TISSUE SPECIFICITY: Expressed in olfactory epithelium, specifically in
CC       the olfactory sensory neurons of the septal organ.
CC       {ECO:0000269|PubMed:10493742, ECO:0000269|PubMed:18214836,
CC       ECO:0000269|PubMed:22328155}.
CC   -!- DEVELOPMENTAL STAGE: Detected at very low levels at 18 dpc and
CC       increased to its maximum level of expression by 7 days after birth in
CC       olfactory sensory neurons of the septal organ.
CC       {ECO:0000269|PubMed:18214836}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255, ECO:0000255|RuleBase:RU000688}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB030894; BAA86125.1; -; Genomic_DNA.
DR   EMBL; AY073295; AAL60958.1; -; Genomic_DNA.
DR   EMBL; AY318728; AAP71857.1; -; Genomic_DNA.
DR   EMBL; AC126025; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH466659; EDL42235.1; -; Genomic_DNA.
DR   EMBL; BC119195; AAI19196.1; -; mRNA.
DR   EMBL; BC119199; AAI19200.1; -; mRNA.
DR   CCDS; CCDS27060.1; -.
DR   RefSeq; NP_065260.2; NM_020514.2.
DR   AlphaFoldDB; Q7TQQ0; -.
DR   SMR; Q7TQQ0; -.
DR   STRING; 10090.ENSMUSP00000046688; -.
DR   GlyGen; Q7TQQ0; 1 site.
DR   iPTMnet; Q7TQQ0; -.
DR   PhosphoSitePlus; Q7TQQ0; -.
DR   PaxDb; Q7TQQ0; -.
DR   PRIDE; Q7TQQ0; -.
DR   Antibodypedia; 58801; 40 antibodies from 14 providers.
DR   DNASU; 57271; -.
DR   Ensembl; ENSMUST00000045066; ENSMUSP00000046688; ENSMUSG00000035626.
DR   Ensembl; ENSMUST00000205900; ENSMUSP00000145819; ENSMUSG00000035626.
DR   Ensembl; ENSMUST00000206100; ENSMUSP00000146173; ENSMUSG00000035626.
DR   Ensembl; ENSMUST00000215030; ENSMUSP00000150016; ENSMUSG00000035626.
DR   GeneID; 57271; -.
DR   KEGG; mmu:57271; -.
DR   UCSC; uc007tpl.2; mouse.
DR   CTD; 57271; -.
DR   MGI; MGI:3031343; Olfr1509.
DR   VEuPathDB; HostDB:ENSMUSG00000035626; -.
DR   eggNOG; ENOG502RCGN; Eukaryota.
DR   GeneTree; ENSGT00940000163275; -.
DR   HOGENOM; CLU_012526_8_1_1; -.
DR   InParanoid; Q7TQQ0; -.
DR   OMA; TLNQTRV; -.
DR   OrthoDB; 1010638at2759; -.
DR   PhylomeDB; Q7TQQ0; -.
DR   TreeFam; TF337251; -.
DR   BioGRID-ORCS; 57271; 1 hit in 65 CRISPR screens.
DR   ChiTaRS; Olfr1509; mouse.
DR   PRO; PR:Q7TQQ0; -.
DR   Proteomes; UP000000589; Chromosome 14.
DR   RNAct; Q7TQQ0; protein.
DR   Bgee; ENSMUSG00000035626; Expressed in vomeronasal organ and 10 other tissues.
DR   ExpressionAtlas; Q7TQQ0; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IMP:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005507; F:copper ion binding; IMP:UniProtKB.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0005549; F:odorant binding; IDA:UniProtKB.
DR   GO; GO:0004984; F:olfactory receptor activity; IDA:UniProtKB.
DR   GO; GO:0050907; P:detection of chemical stimulus involved in sensory perception; IDA:UniProtKB.
DR   GO; GO:0050911; P:detection of chemical stimulus involved in sensory perception of smell; IDA:UniProtKB.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; ISA:MGI.
DR   GO; GO:0007608; P:sensory perception of smell; ISA:MGI.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR000725; Olfact_rcpt.
DR   Pfam; PF13853; 7tm_4; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR00245; OLFACTORYR.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Copper; Disulfide bond; G-protein coupled receptor;
KW   Glycoprotein; Membrane; Metal-binding; Olfaction; Receptor;
KW   Reference proteome; Sensory transduction; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..308
FT                   /note="Olfactory receptor 1509"
FT                   /id="PRO_0000444894"
FT   TOPO_DOM        1..24
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        25..45
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        46..57
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        58..78
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        79..97
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        98..118
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        119..143
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        144..164
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        165..204
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        205..225
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        226..236
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        237..257
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        258..268
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        269..289
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        290..308
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   BINDING         105
FT                   /ligand="Cu cation"
FT                   /ligand_id="ChEBI:CHEBI:23378"
FT                   /evidence="ECO:0000305|PubMed:22328155,
FT                   ECO:0000305|PubMed:25185561"
FT   BINDING         109
FT                   /ligand="Cu cation"
FT                   /ligand_id="ChEBI:CHEBI:23378"
FT                   /evidence="ECO:0000305|PubMed:25185561"
FT   BINDING         260
FT                   /ligand="Cu cation"
FT                   /ligand_id="ChEBI:CHEBI:23378"
FT                   /evidence="ECO:0000305|PubMed:29659735"
FT   CARBOHYD        5
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        97..179
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   MUTAGEN         56
FT                   /note="H->K: Decreased receptor activity in response to
FT                   MTMT binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         59
FT                   /note="M->A: Decreased receptor activity in response to
FT                   MTMT binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         73
FT                   /note="H->A,K,R: No receptor activity in response to MTMT
FT                   binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         73
FT                   /note="H->F,Y: No change in receptor activity in response
FT                   to MTMT binding. No change in the copper-induced
FT                   enhancement of receptor activity."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         97
FT                   /note="C->A,V: No receptor activity in response to MTMT
FT                   binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         97
FT                   /note="C->S: No receptor activity in response to MTMT
FT                   binding, even in the presence of copper. Little to no
FT                   expression detected on plasma membrane."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         105
FT                   /note="H->A,L,R: No receptor activity in response to MTMT
FT                   binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         105
FT                   /note="H->K: Decreased receptor activity in response to
FT                   MTMT binding, even in the presence of copper. Complete loss
FT                   of receptor activity in the absence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         109
FT                   /note="C->M: Decreased receptor activity in response to
FT                   MTMT binding, even in the presence of copper. Shows low
FT                   constitutive activity in the presence of copper. MTMT
FT                   binding in the absence of copper results in an inverse
FT                   agonist effect."
FT                   /evidence="ECO:0000269|PubMed:25185561"
FT   MUTAGEN         109
FT                   /note="C->V: Decreased receptor activity in response to
FT                   MTMT binding, even in the presence of copper. Complete loss
FT                   of receptor activity in the absence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155,
FT                   ECO:0000269|PubMed:25185561"
FT   MUTAGEN         118
FT                   /note="M->A: Decreased receptor activity in response to
FT                   MTMT binding, even in the presence of copper. Complete loss
FT                   of receptor activity in the absence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         127
FT                   /note="C->V: Decreased receptor activity in response to
FT                   MTMT binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         136
FT                   /note="M->A: Decreased receptor activity in response to
FT                   MTMT binding, even in the presence of copper. Complete loss
FT                   of receptor activity in the absence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         141
FT                   /note="C->V: Decreased receptor activity in response to
FT                   MTMT binding, even in the presence of copper. Complete loss
FT                   of receptor activity in the absence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         155
FT                   /note="H->A,K,N,V: No receptor activity in response to MTMT
FT                   binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         155
FT                   /note="H->R: No receptor activity in response to MTMT
FT                   binding, even in the presence of copper. Little to no
FT                   expression detected on plasma membrane."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         169
FT                   /note="C->A,F,V: No receptor activity in response to MTMT
FT                   binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         169
FT                   /note="C->S: No receptor activity in response to MTMT
FT                   binding, even in the presence of copper. Little to no
FT                   expression detected on plasma membrane."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         179
FT                   /note="C->A,V: No receptor activity in response to MTMT
FT                   binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         179
FT                   /note="C->S: No receptor activity in response to MTMT
FT                   binding, even in the presence of copper. Little to no
FT                   expression detected on plasma membrane."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         189
FT                   /note="C->A,V: No receptor activity in response to MTMT
FT                   binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         189
FT                   /note="C->S: Decreased receptor activity in response to
FT                   MTMT binding, even in the presence of copper. Complete loss
FT                   of receptor activity in the absence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         210
FT                   /note="C->A: No change in receptor activity in response to
FT                   MTMT binding in the presence of copper. Decreased receptor
FT                   activity in the absence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         210
FT                   /note="C->S: No change in receptor activity in response to
FT                   MTMT binding in the presence of copper. Complete loss of
FT                   receptor activity in the absence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         210
FT                   /note="C->V: No receptor activity in response to MTMT
FT                   binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         243
FT                   /note="H->A,K: No receptor activity in response to MTMT
FT                   binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         243
FT                   /note="H->R: No receptor activity in response to MTMT
FT                   binding, even in the presence of copper. Little to no
FT                   expression detected on plasma membrane."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         254
FT                   /note="C->V,S: Decreased receptor activity in response to
FT                   MTMT binding, even in the presence of copper. Complete loss
FT                   of receptor activity in the absence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155,
FT                   ECO:0000269|PubMed:29659735"
FT   MUTAGEN         260
FT                   /note="R->H: Decreased receptor activity in response to
FT                   MTMT binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:29659735"
FT   MUTAGEN         260
FT                   /note="R->W,A: No receptor activity in response to MTMT
FT                   binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:29659735"
FT   MUTAGEN         269
FT                   /note="K->A: Decreased receptor activity in response to
FT                   MTMT binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:29659735"
FT   MUTAGEN         269
FT                   /note="K->H: No receptor activity in response to MTMT
FT                   binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:29659735"
FT   MUTAGEN         298
FT                   /note="M->A: Decreased receptor activity in response to
FT                   MTMT binding, even in the presence of copper. Complete loss
FT                   of receptor activity in the absence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         300
FT                   /note="H->K: Decreased receptor activity in response to
FT                   MTMT binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   MUTAGEN         307
FT                   /note="C->V: Decreased receptor activity in response to
FT                   MTMT binding, even in the presence of copper."
FT                   /evidence="ECO:0000269|PubMed:22328155"
FT   CONFLICT        228
FT                   /note="Q -> K (in Ref. 1; BAA86125 and 2; AAL60958)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        248
FT                   /note="A -> T (in Ref. 1; BAA86125 and 2; AAL60958)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   308 AA;  34986 MW;  7F7508A1BCAA20D0 CRC64;
     MGALNQTRVT EFIFLGLTDN WVLEILFFVP FTVTYMLTLL GNFLIVVTIV FTPRLHNPMY
     FFLSNLSFID ICHSSVTVPK MLEGLLLERK TISFDNCIAQ LFFLHLFACS EIFLLTIMAY
     DRYVAICIPL HYSNVMNMKV CVQLVFALWL GGTIHSLVQT FLTIRLPYCG PNIIDSYFCD
     VPPVIKLACT DTYLTGILIV SNSGTISLVC FLALVTSYTV ILFSLRKQSA EGRRKALSTC
     SAHFMVVALF FGPCIFLYTR PDSSFSIDKV VSVFYTVVTP LLNPLIYTLR NEEVKTAMKH
     LRQRRICS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024